Stonepine Capital Management »

Sol Gel Technologies shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Sol Gel Technologies (SLGL) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Sol Gel Technologies

Tip: Access up to 7 years of quarterly data

All positions including Sol Gel Technologies held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sol Gel Technologies by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 28k 79.22

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Sol Gel Technologies

Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Phoenix Holdings
Trails Edge Capital Partners
Citadel Advisors
Affinity Asset Advisors
Squadron Capital Management
Stonepine Capital Management
Yelin Lapidot Holdings Management
XTX Topco
Jane Street
Raymond James Financial
Morgan Stanley
LPL Financial
Hrt Financial

View all funds holding Sol Gel Technologies